Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection.

PloS one - 1 Jan 2016

Feng Jiliang, Zhu Ruidong, Chang Chun, Yu Lu, Cao Fang, Zhu Guohua, Chen Feng, Xia Hui, Lv Fudong, Zhang Shijie, Sun Lin

Abstract excerpt

This retrospective study was designed to investigate the correlation between a novel immunosubtyping method for hepatocellular carcinoma (HCC) and biological behavior of tumor cells. A series of 346 patients, who received hepatectomy at two surgical centers from January 2007 to October 2010, were enrolled in this study. The expressions of cytokeratin 19 (CK19), glypican 3 (GPC3), and CD34 were detected by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glypicans
Share to Hepatectomy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Keratin-19

Share to Lymphatic Metastasis

Share to Neoplasm Grading

Share to Proportional Hazards Models

Share to Sample Size

Share to Single-Blind Method

Source

Open in PubMed Open full text

Identifiers

PMID: 26977595
DOI: 10.1371/journal.pone.0151501
PMCID: PMC4792431

Genes

GPC3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection.PMID 26977595Read ↗

[Correlation analysis between expression of cytokeratin 19 and clinical pathological characteristics and prognosis of dual-phenotype hepatocellular carcinoma].Semantic proximity Read ↗

Biology and function of glypican-3 as a candidate for early cancerous transformation of hepatocytes in hepatocellular carcinomaSemantic proximity Read ↗

Hepatocellular carcinoma expressing cholangiocyte phenotype is a novel subtype with highly aggressive behavior.Semantic proximity Read ↗

Exploring Glypican-3 Targeted CAR-NK Treatment and Potential Therapy Resistance in Hepatocellular CarcinomaSemantic proximity Read ↗

Structural and Functional Impact of Posttranslational Modification of Glypican-3 on Liver CarcinogenesisSemantic proximity Read ↗

Analysis of clinicopathologic and imaging features of dual-phenotype hepatocellular carcinoma.Semantic proximity Read ↗

Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma.Semantic proximity Read ↗

Serum carbohydrate antigen 19-9 and prognosis of patients with gastric cancer.Semantic proximity Read ↗

CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinomaSemantic proximity Read ↗

High expression of embryonic stem cell marker SSEA3 confers poor prognosis and promotes epithelial mesenchymal transition in hepatocellular carcinomaSemantic proximity Read ↗

Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinomaSemantic proximity Read ↗

Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathwaySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.